Cloning, isolation and characterization of human tumor in situ monoclonal antibodies

Cancer Immunology, Immunotherapy : CII
Herren WuJeffry D Watkins

Abstract

A bacterially expressed human antibody (Ab) library (diversity approximately 10(5)) was generated from tumor-infiltrating B lymphocytes present in tissue isolated from a colon tumor. Immunoglobulin (IgG) heavy and light chain variable regions were amplified without isolating or enriching B cells, cloned into a phage-expression vector, and soluble antigen-binding fragment (Fabs) from >10(5) members of the library were screened rapidly by two distinct and complementary methodologies. In the first approach, soluble Fabs were screened by enzyme-linked immunosorbent assay (ELISA) on tumor cell monolayers. Alternatively, tumor cell surface antigens were selectively biotinylated with a plasma membrane-impermeable reagent, solubilized with non-ionic detergent, and were used to screen >10(5) members of the Ab library by capture lift. Reactive Fabs were partially characterized for tumor cell specificity and cross-reactivity, resulting in the identification of multiple Abs that bind cultured tumor cells but not normal human fibroblasts. The Fabs clustered into at least three distinct epitope specificity groups based on multiple criteria, including differential reactivity on two tumor cell lines and distinct antigen recognition patterns on...Continue Reading

Citations

Oct 16, 2003·Current Opinion in Pharmacology·O H Brekke, G Å Løset
Apr 4, 2014·Cancer Immunology, Immunotherapy : CII·Karīna SiliņaAija Linē
Dec 29, 2009·Journal of Biomedicine & Biotechnology·Carmela Dantas-BarbosaAndrea Q Maranhão
Apr 15, 2008·Drug Discovery Today·David R BucklerRobert C Ladner
Apr 28, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Masahide YazakiShu-ichi Ikeda
Nov 19, 2013·Molecular Immunology·Emiliano PavoniOlga Minenkova
Aug 19, 2006·Immunological Investigations·Carolyn J BagloleRichard P Phipps
Aug 6, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Beatrix KotlanMark C Glassy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.